Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds
Source: SeekingAlpha
2026-01-16 08:09:06 ET
More on Vivos Therapeutics
- Vivos Therapeutics signals continued revenue acceleration amid SCN integration and SAMC expansion plans
- Seeking Alpha’s Quant Rating on Vivos Therapeutics
Read the full article on Seeking Alpha
For further details see:
Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds
Vivos Therapeutics Inc.
NASDAQ: VVOS
VVOS Trading
67.94% G/L:
$1.125 Last:
54,524,518 Volume:
$0.7251 Open:
VVOS Latest News
June 05, 2026 08:45:00 am
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing
May 20, 2026 04:10:00 pm
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
VVOS Stock Data
$16,280,184
8,040,995
N/A
7
N/A
Medical Equipment & Supplies
Healthcare
US
Littleton
